CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus CT Angiographic and Plaque Predictors of Functionally Significant Coronary Disease and Outcome Using Machine Learning Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Sleep quality and risk of coronary heart disease-a prospective cohort study from the English longitudinal study of ageing Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies

Original ResearchVolume 73, Issue 22, June 2019

JOURNAL:J Am Coll Cardiol. Article Link

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

DL Bhatt, G Steg, and on behalf of the REDUCE-IT Investigators. Keywords: eicosapentaenoic acid; icosapent ethyl; statin; time-to-first-event;

FULL TEXT PDF